PSCRO November 1, 2019 Articles Abstract Abstract unavailable. Please download related documents below. PSCRO.2019.7e1002 (November 1, 2019) Pranela Rameshwar Download Full Text Download Full Article PDF Download XML DOI: 10.14343/PSCRO.2019.7e1002 Tags: Pranela Rameshwar Continue Reading Previous PostCXCL12-Abundant Reticular (CAR): A Review of the Literature with Relevance to Cancer Stem Cell Survival (2)Next PostStem Cells in Ovarian Cancer and Potential Therapies You Might Also Like Tissue Factor Promotes the Glioma Stem Cell Phenotype, and Is Suppressed by Mutant IDH1 January 3, 2019 Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics February 27, 2015 An emerging question about putative cancer stem cells in established cell lines—are they true stem cells or a fluctuating cell phenotype? February 27, 2015
Tissue Factor Promotes the Glioma Stem Cell Phenotype, and Is Suppressed by Mutant IDH1 January 3, 2019
Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics February 27, 2015
An emerging question about putative cancer stem cells in established cell lines—are they true stem cells or a fluctuating cell phenotype? February 27, 2015